Key result
Higher Glasgow prognostic score linked to ~72% higher risk of death or amputation in CLTI.
Why the study?
The Glasgow prognostic score (GPS), based on C-reactive protein and albumin concentrations, is associated with poor clinical outcomes in cancer, but its prognostic impact on amputation-free survival and wound healing in patients with chronic limb-threatening ischemia (CLTI) undergoing revascularization remained to be clarified.
Does the Glasgow prognostic score predict 1-year amputation-free survival and wound healing in patients with chronic limb-threatening ischemia undergoing revascularization?
Cohort (n=161)
Does the Glasgow prognostic score predict 1-year amputation-free survival and wound healing in patients with chronic limb-threatening ischemia undergoing revascularization?
Answers are grounded in this paper and cite their sources.
The Glasgow Prognostic Score is an independent predictor of 1-year amputation-free survival and wound healing in patients with chronic limb-threatening ischemia undergoing endovascular revascularization, highlighting the prognostic impact of systemic inflammatory and nutritional status.
Background The Glasgow prognostic score (GPS) is an inflammation and nutrition related score based on C-reactive protein and albumin concentrations. GPS has been reported to be associated with poor clinical outcome in patients with cancer. However, it remains to be clarified whether GPS could have prognostic impact in patients with chronic limb-threatening ischemia (CLTI). Purpose To evaluate whether GPS provide long-term prognostic information, such as amputation-free survival (AFS) and wound healing in patients with CLTI undergoing revascularization. Methods We retrospectively analyzed 161 consecutive patients with CLTI treated with revascularization. All participants underwent venous blood sampling and GPS was calculated at the endovascular therapy. GPS was defined using C-reactive protein >1.0 mg/dL and albumin <3.5 g/dL (0–2 points). Primary endpoint was 1-year AFS (death or major amputation within 365 days) and secondary endpoint was 1-year wound healing. GPS was analyzed as a continuous variable (per 1-point increase). Results At 1-year, the amputation-free survival (AFS) rate was 70%, and the wound healing rate was 58%. GPS was significantly higher in patients who experienced AFS events compared with those who did not (1.19 ± 0.13 vs. 0.86 ± 0.08, p = 0.025), Similarly, GPS was significantly lower in patients who achieved wound healing than in those who did not (0.791.14 ± 0.82 vs. 1.14 ± 0.80, p = 0.007). In multivariable Cox regression analysis, higher GPS was independently associated with reduced 1-year amputation-free survival (HR 1.72, 95% CI 1.16–2.60, p = 0.007) after adjustment for age, heart failure, coronary artery disease, and dialysis. Each 1-point increase in GPS was independently associated with reduced in 1-year wound healing (HR 0.75, 95% CI 0.58–0.98; p = 0.037), after adjustment for age, heart failure, and WIfI stage (≥3). Conclusions Glasgow Prognostic Score independently predicts amputation-free survival and wound healing in patients with CLTI. These findings suggest that systemic inflammatory–nutritional status influences limb outcomes beyond anatomical severity alone.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2026) conducted a cohort in Chronic limb-threatening ischemia (CLTI) (n=161). Glasgow prognostic score (GPS) per 1-point increase vs. Lower Glasgow prognostic score was evaluated on 1-year amputation-free survival (death or major amputation within 365 days) (HR 1.72, 95% CI 1.16-2.60, p=0.007). Higher Glasgow prognostic score independently predicted reduced 1-year amputation-free survival in CLTI patients (HR 1.72, 95% CI 1.16-2.60, p=0.007).
Synapse has enriched 10 related papers. Consider them for comparative context: